Guía clínica para el diagnóstico y seguimiento de la distrofia miotónica tipo 1, DM1 o enfermedad de Steinert

Thornton, 2014, Myotonic dystrophy, Neurol Clin, 32, 705, 10.1016/j.ncl.2014.04.011 Fernández-Torrón, 2017, Miotonías distróficas, 417 Grupo de trabajo sobre GPC. Elaboración de guías de práctica clínica den el Sistema Nacional de Salud. Manual metodológico. Madrid: Plan Nacional para el SNS del MSC [3 Jun 2017].]. Disponible en: http://www.guiasalud.es/manual/index.html AGREE Next Steps Consortium. El Instrumento AGREE II versión electrónica. 2009 [consultado 1 Oct 2018]. Diponible en: http://www.agreetrust.org; versión en español: http://www.guiasalud.es Turner, 2010, The myotonic dystrophies: Diagnosis and management, J Neurol Neurosurg Psychiatry., 81, 358, 10.1136/jnnp.2008.158261 Mathieu, 2001, Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy, Neurology, 56, 336, 10.1212/WNL.56.3.336 Gutiérrez-Rivas, 2015, Guía para el seguimiento de la enfermedad de Pompe de comienzo tardío, Rev Neurol, 60, 321 Voet NB, van der Kooi EL, Riphagen II, Lindeman E, van Engelen BG, Geurts AC. Strength training and aerobic exercise training for muscle disease. Cochrane Database Syst Rev. 2013; 7:CD003907. doi: 10.1002/14651858.CD003907.pub4. Jiménez-Moreno, 2018, Falls and resulting fractures in myotonic dystrophy: Results from a multinational retrospective survey, Neuromuscul Disord., 28, 229, 10.1016/j.nmd.2017.12.010 Nitz, 1995, Physiotherapy for myotonic dystrophy, Physiotherapy, 85, 591, 10.1016/S0031-9406(05)66038-5 Logigian, 2010, Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1, Neurology., 74, 1441, 10.1212/WNL.0b013e3181dc1a3a Freyermuth, 2016, Splicing misregulation of SCN5A contributes to cardiac-conduction delay and heart arrhythmia in myotonic dystrophy, Nat Commun, 7, 11067, 10.1038/ncomms11067 Bissay, 2016, SCN4A variants and Brugada syndrome: Phenotypic and genotypic overlap between cardiac and skeletal muscle sodium channelopathies, Eur J Hum Genet, 24, 400, 10.1038/ejhg.2015.125 Otuki, 2017, The effects of pure potassium channel blocker nifekalant and sodium channel blocker mexiletine on malignant ventricular tachyarrhythmias, J Electrocardiol., 50, 277, 10.1016/j.jelectrocard.2016.09.005 De Bellis, 2017, Increased sodium channel use-dependent inhibition by a new potent analogue of tocainide greatly enhances in vivo antimyotonic activity, Neuropharmacology, 113, 206, 10.1016/j.neuropharm.2016.10.013 Trip, 2006, Drug treatment for myotonia, Cochrane Database Syst Rev, 10.1002/14651858.CD004762.pub2 Peric, 2015, Multidimensional aspects of pain in myotonic dystrophies, Acta Myol, 34, 126 Hermans, 2013, Fatigue and daytime sleepiness scale in myotonic dystrophy type 1, Muscle Nerve., 47, 89, 10.1002/mus.23478 Hernández-Vidal, 2000, Concepto y evaluación de la sensación de fatiga, 123 Wintzen, 2007, Does modafinil enhance activity of patients with myotonic dystrophy?: A double-blind placebo-controlled crossover study, J Neurol, 254, 26, 10.1007/s00415-006-0186-z Meola G, Cardani R. Myotonic dystrophy. En: Greenamyre JT, editor-in-chief. MedLink Neurology. San Diego: MedLink Corporation [última actualización 24 Jul 2016]. Disponible en: www.medlink.com Bugiardini, 2014, Consensus on cerebral involvement in myotonic dystrophy Workshop report: May 24-27, 2013, Ferrere (AT), Neuromuscul Disord, 24, 445, 10.1016/j.nmd.2014.01.013 Axford, 2013, Illuminating CNS and cognitive issues in myotonic dystrophy: Workshop report, Neuromuscul Disord, 23, 370, 10.1016/j.nmd.2013.01.003 Sistiaga, 2010, Cognitive/personality pattern and triplet expansion size in adult myotonic dystrophy type 1 (DM1): CTG repeats, cognition and personality in DM1, Psychol Med, 40, 587, 10.1017/S0033291709990602 Modoni, 2004, Characterization of the pattern of cognitive impairmente in myotonic dystrophy type 1, Arch Neurol, 61, 1943, 10.1001/archneur.61.12.1943 Winblad, 2016, Cognition in myotonic dystrophy type 1: A 5-year follow-up, Eur J Neurol, 23, 1471, 10.1111/ene.13062 López López, 2003, Utilidad de las formas cortas de la Escala de Inteligencia de Wechsler para Adultos (WAIS), Anal Psicol, 19, 53 Angeard, 2001, A new window on neurocognitive dysfuyction in the childhood form of myotonic dystrophy type 1 (DM1), Neuromusc Disord, 21, 468, 10.1016/j.nmd.2011.04.009 Douniol M, Jacquette A, Cohen D, Bodeau N, Rachidi L, Angeard N, et al. Psychiatric and cognitive phenotype of childhood myotonic dystrophy type 1. Dev Med Child Neurol. 2012; 54:905-11. Okkersen K, Jimenez-Moreno C, Wenninger S, Daidj F, Glennon J, Cumming S, et al. Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: A multicentre, single-blind, randomised trial. Lancet Neurol. 2018; 17: 671-680. doi: 10.1016/S1474-4422(18)30203-5. Laberge, 2004, Sleep complaints in patients with mytonic dystrophy, J Sleep Res, 13, 95, 10.1111/j.1365-2869.2004.00385.x Romigi, 2011, Sleep disorders in adult-onset myotonic dystrophy type 1: A controlled polysomnographic study, Eur J Neurol, 18, 1139, 10.1111/j.1468-1331.2011.03352.x Johns, 1991, A new method for measuring daytime sleepiness: The Epworth sleepiness scale, Sleep, 14, 540, 10.1093/sleep/14.6.540 Seijas-Gómez, 2015, Estudio descriptivo del perfil neuropsicológico y psicopatológico en pacientes con distrofia miotónica tipo 1, Rev Neurol., 61, 529 Harper, 2004, Myotonic dystrophy, 1039 Gallais, 2015, Prevalence and correlates of apathy in myotonic dystrophy type 1, BMC Neurol, 22, 148, 10.1186/s12883-015-0401-6 Ramos-Brieva, 1986, Validación de la versión castellana de la escala de Hamilton para la depresión, Actas Luso-Esp Neurol Psiquiatr, 14, 324 Biller, 1987, Frequency of cerebral infarction in patients with inherited neuromuscular diseases, Stroke, 18, 805, 10.1161/01.STR.18.4.805 Wahbi, 2016, Atrial flutter in myotonic dystrophy type 1: Patient characteristics and clinical outcome, Neuromuscul Disord, 26, 227, 10.1016/j.nmd.2016.01.005 Yoshida, 2018, The frequency and risk factors for ischemic stroke in myotonic dystrophy type 1 patients, J Stroke Cerebrovasc Dis., 27, 914, 10.1016/j.jstrokecerebrovasdis.2017.10.030 Ashizawa, 1998, Myotonic dystrophy as a brain disorder, Arch Neurol, 55, 291, 10.1001/archneur.55.3.291 Weber, 2010, Comparative analysis of brain structure, metabolism and cognition in myotonic dystrophy type 1 and 2, Neurology, 74, 1108, 10.1212/WNL.0b013e3181d8c35f Serra, 2016, “I know that you know that I know”: Neural substrates associated with social cognition defects in DM1 patients, PLoS One, 11, e0156901, 10.1371/journal.pone.0156901 Serra, 2014, Abnormal functional brain connectivity and personality traits in myotonic dystrophy type 1, JAMA Neurol, 71, 603, 10.1001/jamaneurol.2014.130 Lund, 2014, Cardiac involvement in myotonic dystrophy: A nationwide cohort study, Eur Heart J, 35, 2158, 10.1093/eurheartj/ehu157 Nguyen, 1988, Pathology of the cardiac conduction system in myotonic dystrophy: A study of 12 cases, J Am Coll Cardiol, 11, 662, 10.1016/0735-1097(88)91547-1 Petri, 2012, Cardiac manifestations of myotonic dystrophy type 1, Int J Cardiol, 160, 82, 10.1016/j.ijcard.2011.08.037 Pelargonio, 2002, Myotonic dystrophy and the heart, Heart, 88, 665, 10.1136/heart.88.6.665 Lau, 2015, Myotonic dystrophy and the heart: A systematic review of evaluation and management, Int J Cardiology, 184, 600, 10.1016/j.ijcard.2015.03.069 Lazarus, 2002, Long-term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing: a multicenter diagnostic pacemaker study, J Am Coll Cardiol, 40, 1645, 10.1016/S0735-1097(02)02339-2 Wahbi, 2017, Incidence and predictors of sudden death, major conduction defects and sustained ventricular tachyarrhythmias in 1388 patients with myotonic dystrophy type 1, Eur Heart J, 38, 751 Groh, 2008, Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1, N Eng J Med, 358, 2688, 10.1056/NEJMoa062800 Wahbi, 2012, Electrophysiological study with prophylactic pacing and survival in adults with myotonic dystrophy and conduction system disease, JAMA, 307, 1292, 10.1001/jama.2012.346 Bhakta D1, 2010, Increased mortality with left ventricular systolic dysfunction and heart failure in adults with myotonic dystrophy type 1, Am Heart J, 160, 1137, 10.1016/j.ahj.2010.07.032 Choudhary, 2016, Structural and electrical cardiac abnormalities are prevalent in asymptomatic adults with myotonic dystrophy, Heart, 102, 1472, 10.1136/heartjnl-2015-308517 Priori, 2015, Eur Heart J, 36, 2793, 10.1093/eurheartj/ehv316 Eymard B. Recomendaciones de urgencias. Orphanet. 2014 [consultado 28 May 2018]. Disponible en: https://www.orpha.net/data/patho/ES/Urgencia_DistrofiaMiotonicaSteinert-esPro77.pdf De Die-Smulders, 1998, Age and causes of death in adult-onset myotonic dystrophy, Brain, 121, 1557, 10.1093/brain/121.8.1557 Mathieu, 1999, A 10-year study of mortality in a cohort of patients with myotonic dystrophy, Neurology, 52, 1658, 10.1212/WNL.52.8.1658 Monteiro, 2013, Genetics correlates with lung function and nocturnal ventilation in myotonic dystrohy, Sleep Breath, 17, 1087, 10.1007/s11325-013-0807-6 Marchini, 2000, Correlations between individual clinicalmanifestations and CTG repeat amplification in myotonic dystrophy, Clin Genet, 57, 74, 10.1034/j.1399-0004.2000.570112.x Dogan, 2016, Gender as a modifying factor influencing myotonic dystrophy type 1 phenotype severity and mortality: A nationwide multiple databases cross-sectional observational study, PLoS One., 11, e0148264, 10.1371/journal.pone.0148264 Seijger, 2016, Overweight is an independent risk factor for reduce lung volumes in myotonic dystrophy type 1, PLoS One, 11, e0152344, 10.1371/journal.pone.0152344 Groh, 2011, Survival and CTG repeat expansion in adults with myotonic dystrophy type 1 muscle nerve, 43, 648 Souayah, 2007, Myotonic dystrophy type 1 presenting with ventilatory failure, J Clin Neuromuscul Dis, 9, 252, 10.1097/CND.0b013e3181520095 Sansone, 2015, 207th ENMC Workshop on chronic respiratory insufficiency in myotonic dystrophies: management and implications for research, 27-29 June 2014, Naarden, The Netherlands, Neuromuscul Disord, 25, 432, 10.1016/j.nmd.2015.01.011 Poussel, 2015, Lack of correlation between the ventilatory response to CO2 and lung function impairment in myotonic dystrophy patients: Evidence for a dysregulation at central level, Neuromuscul Disord, 25, 403, 10.1016/j.nmd.2015.02.006 Westa, 2016, Sleepiness and sleep-related breathing disorders in myotonic dystrophy and responses to treatment: A prospective cohort study, J Neuromusc Dis, 3, 529, 10.3233/JND-160191 Moreno-Zabaleta, 2016, Respiratory and sleep disorders in 44 Spanish patients with myotonic dystrophy type I, J Sleep Med Disord, 3, 1069 Giubilei, 1999, Excessive daytime sleepiness in myotonic dystrophy type 1, J Neurol Sci, 164, 60, 10.1016/S0022-510X(99)00042-8 Laberge, 2009, Fatigue and daytime sleepiness in patients with mytonic dystrophy type 1: To lump or Split?, Neuromusc Disord, 19, 397, 10.1016/j.nmd.2009.03.007 Boussaïd, 2016, Factors influencing compliance with non-invasive ventilation at long-term in patients with myotonic dystrophy type 1: A prospective cohort, Neuromuscul Disord., 26, 666, 10.1016/j.nmd.2016.07.014 Schneider-Gold, 2015, Cortical and subcortical grey and white matter atrophy in myotonic dystrophies type 1 and 2 is associated with cognitive impairmente, depression and daytime sleepiness, PLoS Ones, 10, e0130352, 10.1371/journal.pone.0130352 Ercolin, 2013, Oral motor movements and swallowing in patients with myotonic dystrophy type 1, Dysphagia, 28, 446, 10.1007/s00455-013-9458-9 Geh, 1999, Multiple pilomatrixomata and myotonic dystrophy: A familial association, Br J Plast Surg, 52, 143, 10.1054/bjps.1998.3036 Julian, 1998, A clinical review of 209 pilomatricomas, J Am Acad Dermatol, 39, 191, 10.1016/S0190-9622(98)70073-8 Campione, 2017, Cutaneous features of myotonic dystrophy types 1 and 2: Implication of premature aging and vitamin D homeostasis, Neuromusc Dis, 27, 163, 10.1016/j.nmd.2016.11.004 Dahlqvist, 2015, Endocrine function over time in patients with myotonic dystrophy type 1, Eur J Neurol, 22, 116, 10.1111/ene.12542 Smith, 2016, Myotonic dystrophy type 1 management and therapeutics, Curr Treat Options Neurol, 18, 52, 10.1007/s11940-016-0434-1 Vujnic, 2015, Metabolic syndrome in patients with myotonic dystrophy type 1, Muscle Nerve, 52, 273, 10.1002/mus.24540 Fukazawa, 1990, Thyroid function in patients with myotonic dystrophy, Clin Endocrinol (Oxf), 32, 485, 10.1111/j.1365-2265.1990.tb00889.x Steinbeck, 1982, Thyroid abnormalities in patients with myotonic dystrophy, Clin Endocrinol (Oxf), 17, 449, 10.1111/j.1365-2265.1982.tb01612.x Daumerie, 1994, High CTG repeat number in nodular thyroid tissue from a myotonic dystrophy patient, J Med Genet, 31, 891, 10.1136/jmg.31.11.891 Johansson, 2000, Abnormal cytokine and adrenocortical hormone regulation in myotonic dystrophy, J Clin Endocrinol Metab, 85, 3169 Johansson, 2001, Glucocorticoid metabolism and adrenocortical reactivity to ACTH in myotonic dystrophy, J Clin Endocrinol Metab, 86, 4276, 10.1210/jcem.86.9.7865 Froga, 2007, Hipofunción glucocorticoidea en la distrofia miotónica, An Sis Sanit Navar, 30, 199 Misra, 2002, Hyperkalaemia and selective hypoaldosteronism in myotonic dystrophy, Clinical Endocrinology, 56, 271, 10.1046/j.0300-0664.2001.01452.x Iwasaki, 1988, Impaired vasopressin secretion in patients with myotonic dystrophy, H. Nihon Naibunpi Gakkai Zasshi, 64, 69 Cardani, 2008, A putative role of ribonuclear inclusions and MBNL1 in the impairment of gallbladder smooth muscle contractility with cholelithiasis in myotonic dystrophy type 1, Neuromuscul Disord, 18, 641, 10.1016/j.nmd.2008.06.366 Lenard, 1977, Smooth muscle involvement in congenital mytonic dystrophy, Neuropaedriatrie, 8, 42, 10.1055/s-0028-1091503 Pruzanski, 1967, Smooth muscle involvement in primary muscle disease. 1. Myotonic dystrophy, Arch Pathol, 83, 229 Hilbert, 2017, High frequency of gastrointestinal manifestations in myotonic dystrophy type 1 and type 2, Neurology, 89, 1348, 10.1212/WNL.0000000000004420 Pilz, 2014, Oropharyngeal dysphagia in myotonic dystrophy type 1: A systematic review, Dysphagia, 29, 319, 10.1007/s00455-013-9510-9 Burgos, 2012, Traducción y validación de la versión en español de la escala EAT-10 (Eating Assessment Tool-10) para el despistaje de la disfagia, Nutr Hosp, 27, 2048 Pilz, 2014, Swallowing assessment in myotonic dystrophy type 1 using fiberoptic endoscopic evaluation of swallowing (FEES), Neuromuscul Disord, 24, 1054, 10.1016/j.nmd.2014.06.002 Ramos, 1985, El tránsito esofágico en la enfermedad de Steinert, Rev Esp Med Nucl, IV, 159 Gutiérrez-Rivas, 1985, Aclaramiento esofágco en la enfermedad de Steinert, Arch Neurobiol, 68, 362 Gutiérrez-Rivas, 1987, Dismotilidad esofágica en enfermedades neuromusculares, Neurología, 2, 58 Gutiérrez-Rivas, 1985, Oesophageal motor dysfunction in myotonic dystrophy, Neuroscience Letters, 22, 294 Gutiérrez-Rivas, 1994, El vaciamiento gástrico en la distrofia miotónica, Neurología, 9, 477 Benito-León, 1996, Hirschprung's disease in myotonic dystrophy, Muscle Nerve, 22, 1229 Bertrand, 1947, Le megacolon dans Ia maladie de Steinert, Rev Neurol (Paris), 81, 480 Weiner, 1978, Myotonic megacolon in myotonic dystrophy, Am J Roentgenol, 130, 177, 10.2214/ajr.130.1.177 Tarnopolsky, 2010, Bacterial overgrowth syndrome in myotonic muscular dystrophy is potentially treatable, Muscle Nerve, 42, 853, 10.1002/mus.21787 Robert, 1972, Maladie der Steinert et lithiase, Lyon Med, 227, 762 Eckard, 1991, The anal sphincter in patients with myotonic muscular dytrophy, Gastroenterology, 100, 424, 10.1016/0016-5085(91)90212-4 Engvall, 2007, Oral health in children and adolescents with myotonic dystrophy, Eur J Oral Sci, 115, 192, 10.1111/j.1600-0722.2007.00446.x Baptista, 2017, Steinert syndrome and repercussions in dental medicine, Arch Oral Biol, 75, 37, 10.1016/j.archoralbio.2016.12.008 Balasubramaniam, 2008, Oral health considerations in muscular dystrophies, Spec Care Dentist, 28, 243, 10.1111/j.1754-4505.2008.00047.x Zanoteli, 2002, Temporomandibular joint and masticatory muscle involvement in myotonic dystrophy: A study by magnetic resonance imaging, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 94, 262, 10.1067/moe.2002.124580 Ikeda, 2016, Myotonic dystrophy type 1: Frequency of ophthalmologic findings, Arq Neuro-Psiquiatr., 74, 183, 10.1590/0004-282X20150218 Harper, 2001, The eye in myotonic dystrophy, Chapter8, 199 Medica, 2007, Patients with primary cataract as a genetic pool of DMPK protomutation, J Hum Genet., 52, 123, 10.1007/s10038-006-0091-4 Cobo, 1996, Frequency of myotonic dystrophy gene carriers in cataract patients, J Med Genet., 33, 221, 10.1136/jmg.33.3.221 Rosa, 2011, Low intraocular pressure resulting from ciliary body detachment in patients with myotonic dystrophy, Ophthalmology, 118, 260, 10.1016/j.ophtha.2010.06.020 Sansone, 2016, The dystrophic and nondystrophic myotonias, Contin (Minneap Minn), 22, 1889 Harper, 2001 Rudnik-Schoneborn, 2004, Outcome in pregnancies complicated by myotonic dystrophy: A study of 31 patients and review of the literature, Eur J Obstet Gynecol Reprod Biol, 114, 44, 10.1016/j.ejogrb.2003.11.025 https://www.orpha.net/data/patho/Pro/es/Distrofia-miotonica-1-y-2_ES.pdf. [consultado 19 Jun 2018]. White, 2003, Myotonic dystrophy and paediatric anaesthesia, Paediatr Anaesth, 13, 94, 10.1046/j.1460-9592.2003.00889.x Lund, 2014, Risk of cancer in relatives of patients with myotonic dystrophy: A population-based cohort study, Eur J Neurol, 21, 92, 10.1111/ene.12466 Gadalla, 2011, Cancer risk among patients with myotonic muscular dystrophy, JAMA, 306, 2480, 10.1001/jama.2011.1796 Win, 2012, Increased cancer risks in myotonic dystrophy, Mayo Clin Proc, 87, 130, 10.1016/j.mayocp.2011.09.005 Mohamed, 2013, Increasing risk of tumors in myotonic dystrophy type 1 [in French], Presse Med, 42, e281, 10.1016/j.lpm.2013.01.052 Bianchi, 2016, Increased risk of tumor in DM1 is not related to exposure to common lifestyle risk factors, J Neurol, 263, 492, 10.1007/s00415-015-8006-y Abbott, 2016, A population-based survey of risk for cancer in individuals diagnosed with myotonic dystrophy, Muscle Nerve, 54, 783, 10.1002/mus.25145 Fernández-Torrón, 2016, Cancer risk in DM1 is sex-related and linked to miRNA-200/141 downregulation, Neurology, 87, 1250, 10.1212/WNL.0000000000003124 Campbell, 2013, Congenital myotonic dystrophy: Canadian population-based surveillance study, J Pediatr, 163, 120, 10.1016/j.jpeds.2012.12.070 Darin, 2000, Neuromuscular disorders in childhood: A descriptive epidemiological study from western Sweden, Neuromuscul Disord, 10, 1, 10.1016/S0960-8966(99)00055-3 González de Dios, 1999, Estudio epidemiológico de la distrofia miotónica congénita de Steinert: características dismórficas, An Esp Pediatr, 51, 389 Moxley, 2015, Myotonic dystrophy, 697 Mutchnick, 2016, Congenital myotonic dystrophy: Ventriculomegaly and shunt considerations for the pediatric neurosurgeon, Childs Nerv Syst, 32, 609, 10.1007/s00381-015-2993-y Reardon, 1993, The natural history of congenital myotonic dystrophy: Mortality and long term clinical aspects, Arch Dis Child, 68, 177, 10.1136/adc.68.2.177 Campbell, 2004, Congenital myotonic dystrophy: Assisted ventilation duration and outcome, Pediatrics, 113, 811, 10.1542/peds.113.4.811 Wallgren-Pettersson, 2004, 117th ENMC workshop: ventilatory support in congenital neuromuscular disorders— congenital myopathies, congenital muscular dystrophies, congenital myotonic dystrophy, and SMA (II) 4-6 April 2003, Naarden, The Netherlands, Neuromuscular Dis, 14, 56, 10.1016/j.nmd.2003.09.003 Schara, 2006, Myotonic dystrophies type 1 and 2: A summary on current aspects, Semin Pediatr Neurol, 13, 71, 10.1016/j.spen.2006.06.002 Ho, 2015, Congenital and childhood myotonic dystrophy: Current aspects of disease and future directions, World J Clin Pediatr, 4, 66, 10.5409/wjcp.v4.i4.66 Udd, 2012, The myotonic dystrophies: Molecular, clinical, and therapeutic challenges, Lancet Neurol, 11, 891, 10.1016/S1474-4422(12)70204-1 Ekström, 2010, Visual function in congenital and childhood myotonic dystrophy type 1, Ophthalmology, 117, 976, 10.1016/j.ophtha.2010.01.055 Aring, 2012, Ocular motor function in relation to gross motor function in congenital and childhood myotonic dystrophy type 1, Acta Ophthalmol, 90, 369, 10.1111/j.1755-3768.2010.01956.x Bassez, 2004, Severe cardiac arrhythmias in young patients with myotonic dystrophy type 1, Neurology, 63, 1939, 10.1212/01.WNL.0000144343.91136.CF Sharma, 2017, Cardiac abnormalities in congenital and childhood myotonic muscular dystrophy type 1, Neuropediatrics., 48, 42, 10.1055/s-0036-1597546 Canavese, 2009, Orthopaedic manifestations of congenital myotonic dystrophy during childhood and adolescence, J Pediatr Orthop, 29, 208, 10.1097/BPO.0b013e3181982bf6 Leroy, 2007, Les maladies rares aux urgences: état des lieux, Réanimation, 16, 281, 10.1016/j.reaurg.2007.05.005 Orphanet. Cartes de soins et d’urgenes en français [consultado 15 Ene 2018]. Disponible en: http://www.orpha.net/consor/cgi-bin/Disease_Emergency.php?lng=FR&stapage=CARTES_URGENCE_LISTE Faucounneau, 2014, Emergency guidelines and emergency cards, Orphanet J Rare Dis, 9, 10.1186/1750-1172-9-S1-O15 Rosado-Bartolomé, 2016, La distrofia miotónica de Steinert en urgencias, Emergencias, 28, 270 Jimeno Montero C, Gutiérrez Gutiérrez G. Tarjeta de urgencias para los pacientes con distrofia miotónica tipo I (enfermedad de Steinert). Comunicación 320/7. II Encuentro en Continuidad Asistencial, 5 octubre 2017. Subdirección General de Continuidad Asistencial. Servicio Madrileño de Salud.